Concepedia

N M Avdalovic

NM

Statistics

Publications

8

Citations

1.3K

H-Index

8

Active since

1987

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

PDL BioPharma (United States)

N M Avdalovic is an author at Memorial Sloan Kettering Cancer Center specializing in monoclonal antibodies, antibody characterization, and pharmacy.

Publications per year

1987–1993

8

Publications

8

A humanized antibody that binds to the interleukin 2 receptor.

Cary Queen, William P. Schneider, Harold E. Selick et al. · Proceedings of the National Academy of Sciences · 1989 · 628 citations · Full text

, , +17

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

Richard P. Junghans, T. A. Waldmann, Nicholas F. Landolfi et al. · PubMed · 1990 · 151 citations

, , +17

Chimeric and humanized antibodies with specificity for the CD33 antigen

M S Co, N M Avdalovic, Philip Caron et al. · The Journal of Immunology · 1992 · 146 citations

, , +17

Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies.

P C Caron, M S Co, Marcia K. Bull et al. · PubMed · 1992 · 135 citations

, , +17

Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody

Man Sung Co, David A. Scheinberg, N M Avdalovic et al. · Molecular Immunology · 1993 · 72 citations

, , +14

1–5 of 8